A comprehensive view of Inhalers/Sprays/Vaporizers. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Sustainability & Social Responsibility Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Bloomberg: Nasal spray vaccine for COVID could work better than a jab, but head-to-head trial with enough people is needed and can get costly; companies would also face major hurdle of producing large, consistent quantities of vaccine with good shelf life
Published:
August 01, 2022
by The Daily Herald
|
Pet brand maxbone launches beauty line, which features a Calming Shampoo, Coat Spray and Biodegradable Wipe that can help pet owners to achieve salon-quality grooming at home; Shampoo and Spray are cruelty free, soap-free, hypoallergenic and made in USA
Published:
July 22, 2022
by Pet Plus Magazine
|
Patent Issued for Flow governor assemblies for use in medicinal inhalers (USPTO 11376379)
Published:
July 21, 2022
by NewsRx Pharma Business Daily
|
Royalty Pharma buys royalty rights to GSK’s Trelegy Ellipta fluticasone furoate, umeclidinium, vilanterol from Theravance Respiratory for US$1.6B; Trelegy treats chronic obstructive pulmonary disease and asthma, had 2021 sales of US$1.7B
Published:
July 19, 2022
by SeeNews Pharmaceuticals
|
Study finds inhaled corticosteroid asthma drug fluticasone furoate not effective against mild-to-moderate COVID-19; drug was one of three repurposed drugs being tested against COVID-19: Duke Clinical Research Institute
Published:
July 18, 2022
by The Griffon News (Missouri Western State College)
|
Ask us about our Sustainability & Social Responsibility market view
Trending Chart
Interactive chart with headline count